Lakewood-Amedex Biotherapeutics Inc.
LABT· Nasdaq
LABTLakewood-Amedex Biotherapeutics Inc.
Who holds Lakewood-Amedex Biotherapeutics Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Marex Group plc | 48.2K | — | $151.2K | 0.1% | Aug 14, 2026 |
| UBS Group AG | 4.1K | — | $12.9K | 0% | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 624 | — | $2K | 0% | Aug 11, 2026 |
| Osaic Holdings, Inc. | 138 | — | $433 | 0% | Aug 14, 2026 |
| HRT Financial LP | 44.8K | — | $140 | 0.1% | Aug 14, 2026 |
| Blue Trust, Inc. | 11 | — | $35 | 0% | Jul 21, 2026 |
